These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 8118382)

  • 1. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China.
    Qian GS; Ross RK; Yu MC; Yuan JM; Gao YT; Henderson BE; Wogan GN; Groopman JD
    Cancer Epidemiol Biomarkers Prev; 1994; 3(1):3-10. PubMed ID: 8118382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular dosimetry of urinary aflatoxin-DNA adducts in people living in Guangxi Autonomous Region, People's Republic of China.
    Groopman JD; Zhu JQ; Donahue PR; Pikul A; Zhang LS; Chen JS; Wogan GN
    Cancer Res; 1992 Jan; 52(1):45-52. PubMed ID: 1727385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular dosimetry of aflatoxin-N7-guanine in human urine obtained in The Gambia, West Africa.
    Groopman JD; Hall AJ; Whittle H; Hudson GJ; Wogan GN; Montesano R; Wild CP
    Cancer Epidemiol Biomarkers Prev; 1992; 1(3):221-7. PubMed ID: 1339082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma.
    Ross RK; Yuan JM; Yu MC; Wogan GN; Qian GS; Tu JT; Groopman JD; Gao YT; Henderson BE
    Lancet; 1992 Apr; 339(8799):943-6. PubMed ID: 1348796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and antigen-negative residents of Daxin, Qidong County, People's Republic of China.
    Wang JS; Qian GS; Zarba A; He X; Zhu YR; Zhang BC; Jacobson L; Gange SJ; Muñoz A; Kensler TW
    Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):253-61. PubMed ID: 8722216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dosimetry in rat urine of aflatoxin-N7-guanine and other aflatoxin metabolites by multiple monoclonal antibody affinity chromatography and immunoaffinity/high performance liquid chromatography.
    Groopman JD; Hasler JA; Trudel LJ; Pikul A; Donahue PR; Wogan GN
    Cancer Res; 1992 Jan; 52(2):267-74. PubMed ID: 1728400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular epidemiology of aflatoxin exposures: validation of aflatoxin-N7-guanine levels in urine as a biomarker in experimental rat models and humans.
    Groopman JD; Wild CP; Hasler J; Junshi C; Wogan GN; Kensler TW
    Environ Health Perspect; 1993 Mar; 99():107-13. PubMed ID: 8319607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aflatoxin exposure measured by urinary excretion of aflatoxin B1-guanine adduct and hepatitis B virus infection in areas with different liver cancer incidence in Kenya.
    Autrup H; Seremet T; Wakhisi J; Wasunna A
    Cancer Res; 1987 Jul; 47(13):3430-3. PubMed ID: 3034416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China.
    Szymañska K; Chen JG; Cui Y; Gong YY; Turner PC; Villar S; Wild CP; Parkin DM; Hainaut P
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1638-43. PubMed ID: 19366907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for hepatocellular carcinoma in Guangxi, People's Republic of China.
    Yeh FS; Mo CC; Yen RC
    Natl Cancer Inst Monogr; 1985 Dec; 69():47-8. PubMed ID: 3010122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer.
    Egner PA; Wang JB; Zhu YR; Zhang BC; Wu Y; Zhang QN; Qian GS; Kuang SY; Gange SJ; Jacobson LP; Helzlsouer KJ; Bailey GS; Groopman JD; Kensler TW
    Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14601-6. PubMed ID: 11724948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma and aflatoxin exposure in Zhuqing Village, Fusui County, People's Republic of China.
    Wang JS; Huang T; Su J; Liang F; Wei Z; Liang Y; Luo H; Kuang SY; Qian GS; Sun G; He X; Kensler TW; Groopman JD
    Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):143-6. PubMed ID: 11219772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal and urinary excretion of aflatoxin B1 metabolites (AFQ1, AFM1 and AFB-N7-guanine) in young Chinese males.
    Mykkänen H; Zhu H; Salminen E; Juvonen RO; Ling W; Ma J; Polychronaki N; Kemiläinen H; Mykkänen O; Salminen S; El-Nezami H
    Int J Cancer; 2005 Jul; 115(6):879-84. PubMed ID: 15723309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correspondence re: G-S. Qian, et al., A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol., Biomarkers & Prev., 3:3-10, 1994, and C.C. Harris, Solving the viral-chemical puzzle of human liver carcinogenesis. Cancer Epidemiol., Biomarkers & Prev., 3:1-2, 1994.
    Campbell TC
    Cancer Epidemiol Biomarkers Prev; 1994 Sep; 3(6):519-21. PubMed ID: 8000305
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of multiple risk factors for hepatocellular carcinoma on formation of aflatoxin B1-DNA adducts.
    Yu MW; Lien JP; Liaw YF; Chen CJ
    Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):613-9. PubMed ID: 8824363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China.
    Ming L; Thorgeirsson SS; Gail MH; Lu P; Harris CC; Wang N; Shao Y; Wu Z; Liu G; Wang X; Sun Z
    Hepatology; 2002 Nov; 36(5):1214-20. PubMed ID: 12395332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan.
    Wang LY; Hatch M; Chen CJ; Levin B; You SL; Lu SN; Wu MH; Wu WP; Wang LW; Wang Q; Huang GT; Yang PM; Lee HS; Santella RM
    Int J Cancer; 1996 Sep; 67(5):620-5. PubMed ID: 8782648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oltipraz chemoprevention trial in Qidong, People's Republic of China: modulation of serum aflatoxin albumin adduct biomarkers.
    Kensler TW; He X; Otieno M; Egner PA; Jacobson LP; Chen B; Wang JS; Zhu YR; Zhang BC; Wang JB; Wu Y; Zhang QN; Qian GS; Kuang SY; Fang X; Li YF; Yu LY; Prochaska HJ; Davidson NE; Gordon GB; Gorman MB; Zarba A; Enger C; Muñoz A; Helzlsouer KJ
    Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):127-34. PubMed ID: 9488587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aflatoxin metabolism in humans: detection of metabolites and nucleic acid adducts in urine by affinity chromatography.
    Groopman JD; Donahue PR; Zhu JQ; Chen JS; Wogan GN
    Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6492-6. PubMed ID: 3931076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1.
    Sun Z; Lu P; Gail MH; Pee D; Zhang Q; Ming L; Wang J; Wu Y; Liu G; Wu Y; Zhu Y
    Hepatology; 1999 Aug; 30(2):379-83. PubMed ID: 10421643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.